Paraoxonase-1 and arylesterase levels in patients with ulcerative

被引:4
|
作者
Sahin, Memduh [1 ]
Bobusoglu, Onur [2 ]
Yetim, Aylin [3 ]
Ates, Fehmi [4 ]
机构
[1] Saglik Bilimleri Univ, Dept Gastroenterol, Sisli Hamidiye Etfal Training & Res Hosp, Istanbul, Turkey
[2] Mersin Univ, Dept Biochem, Mersin, Turkey
[3] Istanbul Univ, Dept Adeloscent Hlth, Istanbul, Turkey
[4] Mersin Univ, Dept Gastroenterol, Mersin, Turkey
关键词
Ulcerative colitis; Oxidative stress; Paraoxonase; Arylesterase; INFLAMMATORY-BOWEL-DISEASE; OXIDATIVE STRESS; CROHNS-DISEASE;
D O I
10.1016/j.ajg.2019.01.009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and study aims: The role of oxidative stress in inflammatory bowel disease is increasingly recognised as an important factor. It is assumed that reduced levels of paraoxonase-1 (PON-1) and arylesterase (ARE) may lead to increased inflammation due to increased oxidative stress. This study aimed to investigate the relationship between ARE and PON-1 levels in ulcerative colitis (UC) patients and the difference in these levels in UC patients in comparison to the control group. Patients and methods: The study population consisted of 66 (73.3%) UC patients and 24 (26.7%) healthy individuals as the control group. The UC patients and the control group were compared in terms of PON-1 and ARE levels as oxidative stress markers. The UC patients were also grouped according to Mayo UC activity scores, and the differences in their PON-1 and ARE levels were assessed. Results: The ARE values were statistically higher in the control group in comparison to the UC patients. Concentrations of PON-1 were not statistically different in the UC and control groups. The ARE value was found to be significantly lower in the UC patients with a haemoglobin level below 10 mg/dl. There was a correlation between the ARE and PON-1 values in the UC patients, but there was no difference between the ARE and PON-1 values, based on the UC patients' Mayo disease severity scores. Conclusion: This study found that the ARE values of UC patients were lower than those of healthy subjects. The same results could not be determined for PON-1. The data suggest that the antioxidative capacity of UC patients may be reduced. (C) 2019 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 50 条
  • [11] Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naive patients
    Asare, George Awuku
    Andam, Sabina Ekua
    Asare-Anane, Henry
    Ammanquah, Seth
    Anang-Quartey, Yvonne
    Afriyie, Daniel K.
    Musah, Iddis
    PROSTATE INTERNATIONAL, 2018, 6 (01) : 36 - 40
  • [12] Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia
    Romani, Arianna
    Trentini, Alessandro
    van der Flier, Wiesje M.
    Bellini, Tiziana
    Zuliani, Giovanni
    Cervellati, Carlo
    Teunissen, Charlotte E.
    ANTIOXIDANTS, 2020, 9 (05)
  • [13] Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19
    Gabaldo, Xavier
    Juanpere, Marius
    Castane, Helena
    Rodriguez-Tomas, Elisabet
    Felisa Lopez-Azcona, Ana
    Baiges-Gaya, Gerard
    Castro, Lourdes
    Valverde-Diaz, Enrique
    Munoz-Blazquez, Aida
    Gimenez-Cuenca, Laura
    Felipo-Balada, Laura
    Ballester, Frederic
    Pujol, Isabel
    Simo, Josep M.
    Castro, Antoni
    Iftimie, Simona
    Camps, Jordi
    Joven, Jorge
    BIOMOLECULES, 2022, 12 (07)
  • [14] Investigation of serum paraoxonase-1 activity and lipid levels in patients with hyperthyroidism
    Baskol, Gulden
    Dolbun Seckin, Kiymet
    Bayram, Fahri
    Tanriverdi, Fatih
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 : 1166 - 1171
  • [15] Paraoxonase-1 Status in Crohn's Disease and Ulcerative Colitis
    Boehm, Dorota
    Krzystek-Korpacka, Malgorzata
    Neubauer, Katarzyna
    Matusiewicz, Molgorzato
    Berdowska, Lzabela
    Zielinski, Bogdan
    Paradowski, Leszek
    Gamian, Andrzej
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (01) : 93 - 99
  • [16] Paraoxonase and arylesterase levels in rheumatoid arthritis
    Isik, A.
    Koca, S. S.
    Ustundag, B.
    Celik, H.
    Yildirim, A.
    CLINICAL RHEUMATOLOGY, 2007, 26 (03) : 342 - 348
  • [17] Paraoxonase and arylesterase levels in rheumatoid arthritis
    A. Isik
    S. S. Koca
    B. Ustundag
    H. Celik
    A. Yildirim
    Clinical Rheumatology, 2007, 26 : 342 - 348
  • [18] Serum Paraoxonase/Arylesterase Activities and Malondialdehyde Levels in Trauma Patients
    Yildirim, Abdulkadir
    Aslan, Sahin
    Ocak, Tarik
    Yildirim, Serap
    Kara, Fatih
    Sahin, Yasar Nuri
    EURASIAN JOURNAL OF MEDICINE, 2007, 39 (02): : 85 - 88
  • [19] Paraoxonase 1 and arylesterase levels in children with familial mediterranean fever
    Kosan, C.
    Cayir, A.
    Turan, M. I.
    Ustebay, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (03) : 375 - 378
  • [20] Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes
    Wegner, Malgorzata
    Piorunska-Stolzmann, Maria
    Araszkiewicz, Aleksandra
    Zozulinska-Ziolkiewicz, Dorota
    Wierusz-Wysocka, Bogna
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (12): : 448 - 454